Checkpoint Therapeutics Inc CKPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:17 PM EDT
1.92quote price arrow down-0.07 (-3.77%)
Volume
151,776
52 week range
1.30 - 3.62
Loading...
  • Open2.00
  • Day High2.00
  • Day Low1.85
  • Prev Close1.99
  • 52 Week High3.62
  • 52 Week High Date12/07/23
  • 52 Week Low1.30
  • 52 Week Low Date09/26/23

Key Stats

  • Market Cap70.568M
  • Shares Out36.85M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change-16.16

KEY STATS

  • Open2.00
  • Day High2.00
  • Day Low1.85
  • Prev Close1.99
  • 52 Week High3.62
  • 52 Week High Date12/07/23
  • 52 Week Low1.30
  • 52 Week Low Date09/26/23
  • Market Cap70.568M
  • Shares Out36.85M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change-16.16

RATIOS/PROFITABILITY

  • EPS (TTM)-2.37
  • P/E (TTM)-0.81
  • Fwd P/E (NTM)-1.79
  • EBITDA (TTM)-45.013M
  • ROE (TTM)-1,220.38%
  • Revenue (TTM)68,000.004
  • Gross Margin (TTM)-
  • Net Margin (TTM)-76,938.23%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Checkpoint Therapeutics Inc

 

Profile

MORE
Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. The Company is evaluating its lead antibody product candidate, cosibelimab, a potential best-in-class anti-programmed death-ligand 1 (PD-L1) antibody licensed from the Dana-Farber Cancer Institute, as a potential new treatment for patients with selected recurrent...
Michael Weiss J.D.
Chairman of the Board
James Oliviero III
President, Chief Executive Officer, Director
William Gray
Chief Financial Officer, Treasurer, Corporate Secretary
Address
95 SAWYER ROAD, SUITE 110
Waltham, MA
02453
United States

Top Peers

SYMBOLLASTCHG%CHG
INTS
Intensity Therapeutics Inc
4.99+0.15+3.10%
ANTX
AN2 Therapeutics Inc
2.15-0.02-0.69%
CVM
CEL-SCI Corp
1.30-0.01-0.68%
IMMX
Immix Biopharma Inc
2.23-0.07-3.04%
LTRN
Lantern Pharma Inc
6.57+0.29+4.62%